Advanced
Enterprise solutions
Sign in
Sign up
Overview
Locations
Key People
Competitors
Revenue
Financials & Metrics
Follow
Home
/
Xtant Medical
/
Financials & Metrics
Xtant Medical (XTNT) stock price, revenue, and financials
Xtant Medical market cap is $165.6 m, and annual revenue was $53.34 m in FY 2020
View Company
$1.96
+0.05(+2.62%)
Stock price, as of 22-Apr-2021 3:00 pm EST (Market closed)
Previous Close: $1.909999966621399
$165.6 M
XTNT Mkt cap, 19-Apr-2021
$53.3 M
Xtant Medical Revenue FY, 2020
Xtant Medical Gross profit (FY, 2020)
34.4 M
Xtant Medical Gross profit margin (FY, 2020), %
64.5%
Xtant Medical Net income (FY, 2020)
-7 M
Xtant Medical EBIT (FY, 2020)
-751 K
Xtant Medical Cash, 31-Dec-2020
2.3 M
Xtant Medical EV
183.5 M
Xtant Medical Revenue
Xtant Medical revenue was
$53.34 m in FY, 2020
Embed Graph
Xtant Medical Income Statement
Annual
USD
FY, 2011
FY, 2012
FY, 2013
FY, 2014
FY, 2015
FY, 2016
FY, 2017
FY, 2018
FY, 2019
FY, 2020
Revenue
29.7m
33.0m
33.1m
35.3m
59.3m
90.0m
82.6m
72.2m
64.7m
53.3m
Revenue growth, %
7%
68%
52%
Cost of goods sold
9.1m
10.3m
14.2m
13.0m
20.3m
27.7m
32.5m
28.7m
22.2m
18.9m
Gross profit
20.5m
22.6m
18.9m
22.3m
39.1m
62.3m
50.1m
43.5m
42.5m
34.4m
Gross profit Margin, %
69%
69%
57%
63%
66%
69%
61%
60%
66%
64%
Sales and marketing expense
18.5m
15.6m
16.0m
16.9m
28.7m
44.1m
40.5m
32.1m
25.8m
21.0m
R&D expense
1.4m
2.5m
3.4m
2.4m
1.7m
932.0k
657.0k
General and administrative expense
6.6m
11.1m
10.8m
8.9m
13.0m
15.8m
15.2m
12.9m
17.9m
13.5m
Operating expense total
27.5m
27.6m
27.9m
28.6m
51.2m
69.8m
87.9m
103.6m
44.8m
35.1m
Depreciation and amortization
755.4k
377.5k
271.7k
3.8m
4.9m
5.5m
4.1m
58.0k
EBIT
(6.5m)
(4.9m)
(9.0m)
(6.3m)
(12.1m)
(7.5m)
(37.8m)
(60.1m)
(2.3m)
(751.0k)
EBIT margin, %
(22%)
(15%)
(27%)
(18%)
(20%)
(8%)
(46%)
(83%)
(3%)
(1%)
Interest expense
1.2m
1.9m
3.7m
4.2m
7.6m
11.9m
14.6m
10.0m
Pre tax profit
(3.0m)
(7.7m)
(12.7m)
(10.5m)
(19.7m)
(19.4m)
(52.4m)
(70.1m)
(8.1m)
(6.7m)
Income tax expense
(17.5m)
50.4k
(98.0k)
296.0k
Net Income
(3.0m)
(7.7m)
(12.7m)
(10.5m)
(2.2m)
(19.5m)
(52.4m)
(70.1m)
(8.2m)
(7.0m)
Quarterly
USD
Q2, 2011
Q3, 2011
Q1, 2012
Q2, 2012
Q3, 2012
Q1, 2013
Q2, 2013
Q3, 2013
Q1, 2014
Q2, 2014
Q3, 2014
Q1, 2015
Q2, 2015
Q3, 2015
Q1, 2016
Q2, 2016
Q3, 2016
Q1, 2017
Q2, 2017
Q3, 2017
Q1, 2018
Q2, 2018
Q3, 2018
Q1, 2019
Q2, 2019
Q3, 2019
Q1, 2020
Q2, 2020
Q3, 2020
Revenue
7.4m
7.2m
7.7m
8.2m
8.9m
8.6m
8.3m
7.9m
8.9m
8.9m
8.5m
9.5m
9.9m
17.7m
21.0m
21.5m
23.1m
22.1m
21.4m
19.8m
17.9m
18.7m
17.3m
16.7m
15.3m
15.7m
14.8m
10.5m
14.0m
Cost of goods sold
1.7m
1.3m
1.9m
2.3m
2.6m
3.1m
3.6m
3.3m
3.4m
3.3m
3.5m
3.4m
6.0m
6.9m
6.8m
7.1m
7.2m
7.9m
8.4m
5.7m
6.3m
5.7m
5.9m
5.4m
5.2m
5.2m
4.0m
4.8m
Gross profit
5.6m
5.9m
5.8m
5.9m
6.3m
5.5m
4.7m
4.6m
5.5m
5.6m
6.0m
6.5m
11.7m
14.1m
14.7m
16.0m
14.9m
13.5m
11.4m
12.2m
12.5m
11.5m
10.8m
9.9m
10.5m
9.6m
6.6m
9.2m
Gross profit Margin, %
76%
82%
76%
72%
71%
64%
57%
58%
62%
63%
63%
66%
66%
67%
69%
69%
68%
63%
57%
68%
67%
67%
65%
65%
67%
65%
62%
66%
Sales and marketing expense
4.3m
4.8m
4.1m
3.8m
3.4m
3.8m
4.2m
4.1m
4.1m
4.4m
3.9m
4.7m
5.0m
8.4m
10.5m
10.4m
11.2m
11.0m
11.1m
8.9m
8.3m
8.5m
7.8m
6.7m
6.1m
6.7m
6.4m
3.9m
5.3m
R&D expense
254.6k
322.3k
378.3k
433.6k
291.2k
794.5k
899.6k
783.9k
928.9k
698.6k
640.0k
504.2k
414.0k
418.0k
347.0k
262.0k
210.0k
203.0k
245.0k
111.0k
176.0k
General and administrative expense
1.4m
2.1m
2.6m
2.3m
2.4m
2.9m
2.3m
2.8m
2.3m
2.1m
2.3m
2.4m
2.4m
4.0m
3.5m
3.9m
3.8m
4.1m
4.5m
3.3m
3.0m
3.4m
2.5m
4.2m
4.0m
4.2m
4.3m
2.9m
3.0m
Operating expense total
6.0m
7.8m
7.2m
6.2m
6.1m
6.7m
6.6m
7.0m
6.7m
6.9m
6.7m
7.8m
7.9m
16.5m
16.5m
16.8m
17.9m
17.5m
18.2m
14.9m
13.9m
14.7m
13.0m
11.5m
10.5m
11.2m
11.0m
6.9m
8.5m
Depreciation and amortization
157.0k
213.2k
119.1k
97.9k
75.1k
82.4k
58.8k
124.1k
100.7k
1.5m
1.2m
1.2m
1.3m
1.3m
1.5m
1.4m
1.0m
1.0m
1.0m
159.0k
146.0k
137.0k
EBIT
(280.0k)
(1.6m)
(1.3m)
(347.4k)
212.7k
(1.2m)
(1.9m)
(2.3m)
(1.2m)
(1.3m)
(1.3m)
(1.7m)
(1.4m)
(4.9m)
(2.4m)
(2.1m)
(1.9m)
(2.6m)
(4.7m)
(3.5m)
(1.7m)
(2.3m)
(1.4m)
(668.0k)
(563.0k)
(705.0k)
(1.4m)
(387.0k)
760.0k
EBIT margin, %
(4%)
(22%)
(17%)
(4%)
2%
(14%)
(23%)
(30%)
(13%)
(15%)
(15%)
(18%)
(14%)
(28%)
(11%)
(10%)
(8%)
(12%)
(22%)
(18%)
(9%)
(12%)
(8%)
(4%)
(4%)
(4%)
(9%)
(4%)
5%
Interest expense
132.9k
541.2k
142.9k
266.2k
867.9k
1.1m
1.2m
2.0m
2.9m
568.4k
1.5m
2.4m
1.5m
2.1m
3.2m
2.3m
3.2m
3.2m
5.0m
3.8m
3.6m
2.7m
1.7m
2.1m
1.4m
1.2m
Pre tax profit
(405.3k)
(3.2m)
(1.0m)
730.5k
(2.5m)
(1.7m)
(2.5m)
(4.4m)
(2.8m)
(1.9m)
(1.9m)
(2.5m)
(2.4m)
(1.3m)
Income tax expense
(23.0k)
22.0k
23.0k
22.0k
23.0k
23.0k
Net Income
(405.3k)
(3.2m)
(1.0m)
730.5k
(2.5m)
(1.7m)
(2.5m)
(4.4m)
(4.1m)
(1.9m)
(1.2m)
(4.2m)
(2.9m)
(5.6m)
(4.5m)
(5.8m)
(9.7m)
(5.3m)
(5.0m)
(3.2m)
(2.8m)
(1.9m)
(1.9m)
(2.5m)
(2.5m)
(1.4m)
Xtant Medical Balance Sheet
Annual
USD
FY, 2011
FY, 2012
FY, 2013
FY, 2014
FY, 2015
FY, 2016
FY, 2017
FY, 2018
FY, 2019
FY, 2020
Cash
751.1k
4.9m
3.0m
4.5m
6.4m
2.6m
2.9m
6.8m
5.2m
2.3m
Accounts Receivable
7.1m
7.2m
4.8m
4.4m
15.4m
12.7m
10.0m
10.1m
6.9m
Prepaid Expenses
289.3k
353.3k
574.9k
654.1k
985.5k
1.7m
589.0k
784.0k
736.0k
Inventories
8.5m
13.1m
10.8m
9.6m
22.7m
22.2m
17.3m
16.1m
21.4m
Current Assets
16.6m
25.6m
19.2m
19.1m
45.4m
49.0m
39.5m
34.7m
32.2m
31.4m
PP&E
3.8m
5.2m
5.2m
4.7m
11.8m
15.8m
9.9m
7.2m
4.7m
4.3m
Goodwill
728.6k
728.6k
41.5m
41.5m
41.5m
3.2m
3.2m
3.2m
Total Assets
23.2m
34.5m
28.9m
28.0m
143.1m
144.1m
105.7m
46.4m
43.2m
41.5m
Accounts Payable
2.7m
4.0m
2.8m
3.9m
9.4m
10.5m
9.3m
6.5m
2.2m
2.3m
Short-term debt
1.6m
45.1k
219.7k
112.6k
35.1k
244.8k
365.5k
426.0k
394.0k
17.2m
Current Liabilities
10.9m
8.7m
9.7m
8.5m
21.5m
31.1m
25.8m
12.1m
9.4m
25.6m
Long-term debt
6.6m
14.5m
16.5m
20.9m
112.7m
67.7m
78.1m
78.0m
3.0m
Total Debt
8.3m
14.5m
47.7k
21.0m
244.8k
365.5k
426.0k
78.4m
20.2m
Total Liabilities
17.7m
30.3m
32.7m
35.7m
134.2m
151.2m
164.4m
90.2m
87.4m
27.0m
Common Stock
40.0
43.0
53.0
7.0
11.0
2.0
Preferred Stock
Additional Paid-in Capital
45.5m
51.9m
56.5m
63.1m
81.9m
85.5m
86.2m
171.3m
179.1m
244.9m
Retained Earnings
(40.0m)
(47.7m)
(60.4m)
(70.9m)
(73.0m)
(92.5m)
(144.9m)
(215.0m)
(223.3m)
(230.3m)
Total Equity
5.5m
4.2m
(3.8m)
(7.8m)
8.9m
(7.1m)
(58.7m)
(43.8m)
(44.2m)
14.5m
Debt to Equity Ratio
1.5 x
3.4 x
0 x
-2.7 x
0 x
0 x
0 x
Debt to Assets Ratio
0.4 x
0.4 x
0 x
0.8 x
0 x
0 x
0 x
Financial Leverage
4.2 x
8.2 x
-7.5 x
-3.6 x
16.1 x
-20.4 x
-1.8 x
-1.1 x
-1 x
2.9 x
Quarterly
USD
Q2, 2011
Q3, 2011
Q1, 2012
Q2, 2012
Q3, 2012
Q1, 2013
Q2, 2013
Q3, 2013
Q1, 2014
Q2, 2014
Q3, 2014
Q1, 2015
Q2, 2015
Q3, 2015
Q1, 2016
Q2, 2016
Q3, 2016
Q1, 2017
Q2, 2017
Q3, 2017
Q1, 2018
Q2, 2018
Q3, 2018
Q1, 2019
Q2, 2019
Q3, 2019
Q1, 2020
Q2, 2020
Q3, 2020
Cash
1.4m
1.8m
1.4m
1.2m
8.6m
2.1m
5.1m
3.4m
4.8m
3.0m
7.0m
2.9m
2.0m
8.0m
4.7m
2.2m
1.4m
2.5m
1.7m
2.1m
6.2m
6.0m
5.1m
7.1m
7.3m
5.7m
3.2m
3.0m
2.7m
Accounts Receivable
5.5m
6.4m
7.6m
6.6m
7.2m
7.2m
6.2m
4.6m
5.5m
4.9m
4.3m
5.5m
5.6m
13.3m
14.9m
14.7m
15.8m
16.3m
15.8m
13.9m
10.3m
10.4m
9.9m
9.5m
8.6m
9.1m
9.7m
7.6m
7.3m
Prepaid Expenses
480.2k
410.6k
421.3k
586.0k
630.4k
742.8k
667.9k
486.7k
981.5k
1.0m
808.2k
885.4k
1.0m
1.0m
858.4k
1.3m
2.0m
1.7m
831.2k
664.6k
1.1m
801.0k
738.0k
464.0k
592.0k
714.0k
1.1m
899.0k
1.7m
Inventories
6.4m
7.7m
10.4m
12.3m
13.4m
13.6m
13.8m
13.2m
10.5m
10.5m
11.1m
9.7m
9.4m
22.0m
24.2m
25.5m
26.5m
26.4m
24.9m
24.0m
22.5m
22.4m
22.2m
16.5m
15.8m
16.0m
18.0m
19.9m
20.7m
Current Assets
14.5m
17.0m
19.8m
20.7m
29.8m
23.6m
25.8m
21.8m
21.8m
19.4m
23.2m
19.0m
18.0m
44.4m
44.7m
43.7m
45.8m
46.8m
43.3m
40.7m
40.1m
39.7m
37.9m
33.6m
32.3m
31.6m
32.1m
31.4m
32.4m
PP&E
3.4m
3.5m
4.1m
4.5m
4.9m
5.5m
5.5m
5.3m
5.0m
4.9m
4.8m
4.5m
4.4m
11.4m
13.8m
15.6m
16.0m
14.6m
13.4m
11.5m
9.3m
8.9m
8.1m
6.4m
5.6m
5.1m
4.3m
4.3m
4.1m
Goodwill
728.6k
728.6k
728.6k
728.6k
728.6k
728.6k
728.6k
24.0m
41.5m
41.5m
41.5m
41.5m
41.5m
41.5m
41.5m
41.5m
41.5m
3.2m
3.2m
3.2m
3.2m
3.2m
3.2m
Total Assets
19.8m
23.4m
26.7m
28.5m
38.4m
32.7m
35.1m
31.0m
31.2m
28.4m
31.8m
27.4m
26.4m
126.2m
141.4m
141.3m
142.4m
139.1m
133.7m
128.5m
104.8m
102.8m
99.3m
47.1m
44.5m
43.0m
42.6m
41.7m
42.4m
Accounts Payable
2.5m
2.2m
3.9m
3.6m
4.1m
4.0m
4.2m
3.2m
4.2m
4.2m
3.9m
4.4m
4.6m
7.5m
12.4m
12.8m
12.9m
8.9m
8.4m
7.4m
7.5m
7.5m
5.9m
6.0m
3.2m
2.2m
3.6m
3.1m
2.8m
Short-term debt
907.1k
1.1m
2.3m
4.3m
44.5k
45.6k
46.3k
212.9k
218.7k
195.9k
159.2k
82.5k
95.1k
100.4k
30.2k
5.7m
8.6m
10.6m
302.1k
65.9m
383.0k
469.0k
478.0k
73.0m
337.0k
229.0k
401.0k
408.0k
415.0k
Current Liabilities
6.5m
7.5m
11.5m
11.8m
8.8m
8.4m
9.5m
8.9m
11.6m
9.8m
9.4m
10.4m
10.3m
16.7m
25.6m
25.6m
28.5m
28.9m
20.8m
87.2m
12.0m
12.4m
10.4m
11.3m
9.9m
9.1m
10.1m
9.5m
9.3m
Long-term debt
4.3m
7.1m
6.0m
6.4m
14.2m
14.7m
15.3m
16.2m
19.7m
20.1m
20.5m
21.3m
21.7m
112.3m
112.4m
116.2m
119.1m
51.8m
64.0m
71.4m
77.2m
79.8m
76.2m
75.0m
75.6m
76.8m
79.0m
79.0m
81.0m
Total Debt
5.2m
8.2m
8.3m
10.6m
14.3m
14.8m
15.4m
47.0k
48.4k
49.2k
49.9k
21.4m
52.4k
53.2k
30.2k
203.6k
209.8k
259.0k
302.1k
319.1k
383.0k
469.0k
478.0k
148.0m
76.0m
77.0m
79.4m
79.5m
81.5m
Total Liabilities
10.8m
14.7m
17.7m
18.3m
29.9m
30.1m
31.7m
31.7m
37.8m
36.4m
36.3m
37.9m
38.2m
129.1m
138.0m
141.8m
147.5m
151.4m
155.6m
158.7m
89.2m
92.2m
86.6m
86.2m
85.6m
85.9m
89.0m
88.5m
90.4m
Common Stock
38.0
40.0
43.0
43.0
43.0
43.0
52.0
52.0
55.0
6.0
7.0
7.0
7.0
11.0
11.0
11.0
11.0
18.0
18.0
18.0
Preferred Stock
Additional Paid-in Capital
41.4m
44.3m
50.0m
50.4m
51.4m
52.0m
55.3m
55.6m
57.9m
58.4m
63.1m
64.6m
66.1m
81.8m
82.0m
82.6m
82.9m
86.0m
86.1m
86.3m
165.8m
165.8m
171.0m
178.7m
178.7m
178.8m
179.3m
181.4m
181.6m
Retained Earnings
(32.4m)
(35.6m)
(41.0m)
(40.3m)
(42.8m)
(49.3m)
(51.8m)
(56.2m)
(64.5m)
(66.4m)
(67.6m)
(75.0m)
(77.9m)
(84.6m)
(78.6m)
(83.1m)
(88.0m)
(98.3m)
(108.0m)
(116.5m)
(150.2m)
(155.5m)
(158.4m)
(217.8m)
(219.8m)
(221.7m)
(225.8m)
(228.3m)
(229.6m)
Total Equity
9.0m
8.7m
9.0m
10.1m
8.6m
2.7m
3.4m
(636.0k)
(6.6m)
(8.0m)
(4.5m)
(10.5m)
(11.8m)
(2.8m)
3.4m
(496.3k)
(5.1m)
(12.3m)
(21.9m)
(30.2m)
15.6m
10.6m
12.7m
(39.2m)
(41.1m)
(42.9m)
(46.5m)
(46.9m)
(48.0m)
Debt to Equity Ratio
0.6 x
0.9 x
0.9 x
1 x
1.7 x
5.6 x
4.5 x
-0.1 x
0 x
0 x
0 x
-2 x
0 x
0 x
0 x
-0.4 x
0 x
0 x
0 x
0 x
0 x
0 x
0 x
-3.8 x
-1.8 x
Debt to Assets Ratio
0.3 x
0.4 x
0.3 x
0.4 x
0.4 x
0.5 x
0.4 x
0 x
0 x
0 x
0 x
0.8 x
0 x
0 x
0 x
0 x
0 x
0 x
0 x
0 x
0 x
0 x
0 x
3.1 x
1.7 x
Financial Leverage
2.2 x
2.7 x
3 x
2.8 x
4.5 x
12.3 x
10.2 x
-48.8 x
-4.8 x
-3.6 x
-7.1 x
-2.6 x
-2.2 x
-44.6 x
42.1 x
-284.7 x
-27.9 x
-11.3 x
-6.1 x
-4.2 x
6.7 x
9.7 x
7.8 x
-1.2 x
-1.1 x
-1 x
-0.9 x
-0.9 x
-0.9 x
Xtant Medical Cash Flow
Annual
USD
FY, 2011
FY, 2012
FY, 2013
FY, 2014
FY, 2015
FY, 2016
FY, 2017
FY, 2018
FY, 2019
FY, 2020
Net Income
(3.0m)
(7.7m)
(12.7m)
(10.5m)
(2.2m)
(19.5m)
(52.4m)
(70.1m)
(8.2m)
(7.0m)
Depreciation and Amortization
755.4k
782.9k
753.5k
952.3k
4.9m
7.2m
8.4m
6.6m
3.1m
2.1m
Accounts Receivable
(4.6m)
(414.9k)
797.7k
283.6k
(5.5m)
(2.7m)
4.7m
2.5m
(647.0k)
2.9m
Inventories
(2.4m)
(5.3m)
747.7k
(17.4k)
(545.7k)
(4.1m)
2.1m
40.0k
692.0k
(5.8m)
Accounts Payable
334.2k
1.2m
(1.0m)
715.7k
644.1k
319.1k
(1.6m)
(3.0m)
(4.3m)
101.0k
Cash From Operating Activities
(7.4m)
(10.8m)
(5.6m)
(7.3m)
(9.1m)
(14.4m)
(543.2k)
1.2m
(413.0k)
(731.0k)
Purchases of PP&E
(962.3k)
(1.8m)
(623.0k)
(300.0k)
(2.3m)
(5.8m)
(1.6m)
(624.0k)
(879.0k)
(1.5m)
Cash From Investing Activities
(1.0m)
(1.8m)
35.3k
(298.4k)
(73.6m)
(5.8m)
(1.6m)
(367.0k)
(544.0k)
(1.3m)
Long-term Borrowings
(5.1m)
(9.8m)
(771.7k)
(825.4k)
(1.4m)
(144.6k)
(88.2k)
(359.0k)
(455.0k)
(471.0k)
Cash From Financing Activities
8.8m
16.8m
3.7m
9.0m
84.6m
16.4m
2.4m
3.1m
(603.0k)
(861.0k)
Net Change in Cash
423.6k
4.2m
(1.9m)
1.4m
1.9m
(3.8m)
277.7k
3.9m
(1.6m)
(2.9m)
Interest Paid
1.9m
Income Taxes Paid
Quarterly
USD
Q2, 2011
Q3, 2011
Q1, 2012
Q2, 2012
Q3, 2012
Q1, 2013
Q2, 2013
Q3, 2013
Q1, 2014
Q2, 2014
Q3, 2014
Q1, 2015
Q2, 2015
Q3, 2015
Q1, 2016
Q2, 2016
Q3, 2016
Q1, 2017
Q2, 2017
Q3, 2017
Q1, 2018
Q2, 2018
Q3, 2018
Q1, 2019
Q2, 2019
Q3, 2019
Q1, 2020
Q2, 2020
Q3, 2020
Net Income
4.5m
1.3m
(1.0m)
(316.3k)
(2.8m)
(1.7m)
(4.2m)
(8.5m)
(4.1m)
(6.0m)
(7.2m)
(4.2m)
(7.1m)
(13.8m)
(5.6m)
(10.1m)
(15.0m)
(5.8m)
(15.5m)
(24.0m)
(5.3m)
(10.3m)
(13.4m)
(2.8m)
(4.7m)
(6.6m)
(2.5m)
(5.0m)
(6.3m)
Depreciation and Amortization
590.1k
803.3k
213.5k
403.3k
577.1k
200.4k
394.8k
586.8k
169.1k
345.6k
498.3k
235.1k
446.8k
2.4m
1.8m
3.6m
5.6m
2.1m
4.2m
7.4m
1.6m
3.2m
7.5m
776.0k
1.6m
2.3m
685.0k
1.2m
1.7m
Accounts Receivable
(1.9m)
(2.9m)
(525.7k)
524.2k
(237.8k)
(106.9k)
156.3k
971.0k
(836.6k)
(220.5k)
346.2k
(993.8k)
(1.1m)
(2.8m)
328.3k
207.9k
(859.0k)
2.5m
2.5m
4.1m
2.3m
2.2m
2.8m
403.0k
1.4m
417.0k
195.0k
2.3m
2.5m
Inventories
(883.2k)
(1.5m)
(2.0m)
(3.9m)
(5.1m)
(455.8k)
(148.9k)
265.4k
238.6k
306.9k
(350.2k)
147.7k
209.8k
477.8k
(1.1m)
(2.7m)
(4.0m)
261.2k
1.2m
1.7m
(182.0k)
(388.0k)
(508.0k)
623.0k
955.0k
760.0k
(2.0m)
(4.2m)
(5.0m)
Accounts Payable
(353.8k)
(200.0k)
1.3m
1.0m
1.3m
(145.0k)
307.8k
(636.0k)
1.4m
1.0m
884.4k
610.7k
742.8k
694.3k
3.7m
3.7m
3.2m
(1.7m)
(2.4m)
(3.4m)
(1.9m)
(1.9m)
(3.6m)
(429.0k)
(3.5m)
(4.2m)
1.4m
884.0k
626.0k
Cash From Operating Activities
(4.4m)
(6.4m)
(2.9m)
(4.9m)
(7.8m)
(2.3m)
(3.6m)
(5.2m)
(2.2m)
(3.9m)
(5.2m)
(2.1m)
(4.1m)
(9.0m)
1.0m
(7.8m)
(11.2m)
436.2k
(756.7k)
(1.2m)
236.0k
344.0k
(779.0k)
490.0k
954.0k
(342.0k)
(1.8m)
(1.6m)
(1.6m)
Purchases of PP&E
(269.4k)
(549.3k)
(347.7k)
(870.6k)
(1.2m)
(477.8k)
(579.9k)
(633.4k)
(54.9k)
(115.2k)
(190.6k)
(48.8k)
(70.4k)
(444.3k)
(2.7m)
(4.4m)
(5.6m)
(310.1k)
(1.1m)
(1.5m)
(132.0k)
(288.0k)
(308.0k)
(137.0k)
(211.0k)
(403.0k)
(258.0k)
(673.0k)
(907.0k)
Cash From Investing Activities
(377.5k)
(599.0k)
(347.7k)
(870.6k)
(1.2m)
(477.8k)
(590.1k)
(643.5k)
(18.9k)
(79.1k)
(180.5k)
(32.4k)
(54.0k)
(73.4m)
(2.7m)
(4.4m)
(5.6m)
(310.1k)
(1.1m)
(1.5m)
(132.0k)
(288.0k)
(57.0k)
(86.0k)
(48.0k)
(162.0k)
(175.0k)
(567.0k)
(734.0k)
Short-term Borrowings
(154.6k)
(10.4m)
(10.4m)
Long-term Borrowings
(86.2k)
(5.1m)
(10.7k)
(445.5k)
(9.8m)
(12.0k)
(22.9k)
(144.4k)
(70.0k)
(107.2k)
(619.4k)
(208.0k)
(90.2k)
(117.2k)
(8.0k)
(49.4k)
(80.1k)
(63.0k)
(27.9k)
(203.4k)
(79.0k)
(167.0k)
(260.0k)
(104.0k)
(277.0k)
(395.0k)
(34.0k)
(75.0k)
(115.0k)
Cash From Financing Activities
5.9m
8.5m
3.9m
6.2m
16.9m
(47.6k)
4.4m
4.3m
3.9m
3.9m
9.3m
542.0k
1.7m
85.8m
(8.0k)
8.0m
11.8m
(217.6k)
910.9k
2.1m
3.2m
3.1m
3.0m
(104.0k)
(385.0k)
(544.0k)
(34.0k)
(75.0k)
(115.0k)
Net Change in Cash
1.1m
1.5m
612.5k
462.5k
7.9m
(2.8m)
209.9k
(1.5m)
1.7m
(56.9k)
3.9m
(1.6m)
(2.4m)
3.4m
(1.7m)
(4.2m)
(5.0m)
(91.4k)
(913.7k)
(509.2k)
3.3m
3.2m
2.2m
300.0k
521.0k
(1.0m)
(2.0m)
(2.2m)
(2.5m)
Interest Paid
483.3k
815.0k
1.9m
2.2m
Income Taxes Paid
Xtant Medical Ratios
USD
Q2, 2011
Debt/Equity
0.6 x
Debt/Assets
0.3 x
Financial Leverage
2.2 x
Report incorrect company information
Xtant Medical Employee Rating
2.5
17 votes
Culture & Values
2.5
Work/Life Balance
2.9
Senior Management
1.9
Salary & Benefits
2.4
Career Opportunities
2.3
Source
View Xtant Medical profile
Competitors
ACell
Healthcare - Public
Medistim
Healthcare - Public
XENAMED Industries
Healthcare - Private
Deltex Medical
Healthcare - Public
Compare competitors